Gene · 79885
Papers2,024
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,024
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic and epigenetic targets of natural dietary compounds as anti-Alzheimer's agents. | Neural Regen Res | 2024 | 37843220 | PubTator, text mining | PubMed |
| Acetylation and Phosphorylation in the Regulation of Hypoxia-Inducible Factor Activities: Additional Options to Modulate Adaptations to Changes in Oxygen Levels. | Life (Basel) | 2023 | 38276269 | PubTator, text mining | PubMed |
| Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer. | Pharmaceutics | 2023 | 38258065 | PubTator, text mining | PubMed |
| FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | Int J Mol Sci | 2023 | 38203448 | PubTator, text mining | PubMed |
| Epigallocatechin-3-gallate and its nanoformulation in cervical cancer therapy: the role of genes, MicroRNA and DNA methylation patterns. | Cancer Cell Int | 2023 | 38129839 | PubTator, text mining | PubMed |
| TMP269, a small molecule inhibitor of class IIa HDAC, suppresses RABV replication in vitro. | Front Microbiol | 2023 | 38107853 | PubTator, text mining | PubMed |
| Functioning and mechanisms of PTMs in renal diseases. | Front Pharmacol | 2023 | 38074159 | PubTator, text mining | PubMed |
| HDAC1: An Essential and Conserved Member of the Diverse Zn2+-Dependent HDAC Family Driven by Divergent Selection Pressure. | Int J Mol Sci | 2023 | 38069395 | PubTator, text mining | PubMed |
| A novel chimeric RNA originating from BmCPV S4 and Bombyx mori HDAC11 transcripts regulates virus proliferation. | PLoS Pathog | 2023 | 38048361 | PubTator, text mining | PubMed |
| Targeting the epigenome to reinvigorate T cells for cancer immunotherapy. | Mil Med Res | 2023 | 38044445 | PubTator, text mining | PubMed |
| DNA methylation and histone post-translational modifications in atherosclerosis and a novel perspective for epigenetic therapy. | Cell Commun Signal | 2023 | 38031118 | PubTator, text mining | PubMed |
| Histone deacetylase inhibitor pracinostat suppresses colorectal cancer by inducing CDK5-Drp1 signaling-mediated peripheral mitofission. | J Pharm Anal | 2023 | 38024857 | PubTator, text mining | PubMed |
| Gasdermins in sepsis. | Front Immunol | 2023 | 38022612 | PubTator, text mining | PubMed |
| Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer. | Pharmaceutics | 2023 | 38004560 | PubTator, text mining | PubMed |
| Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents. | Nutrients | 2023 | 38004113 | PubTator, text mining | PubMed |
| Epigenetic Dysregulation and Its Correlation with the Steroidogenic Machinery Impacting Breast Pathogenesis: Data Mining and Molecular Insights into Therapeutics. | Int J Mol Sci | 2023 | 38003678 | PubTator, text mining | PubMed |
| The Role of Non-Coding RNAs in Epigenetic Dysregulation in Glioblastoma Development. | Int J Mol Sci | 2023 | 38003512 | PubTator, text mining | PubMed |
Elucidating the Histone Deacetylase Gene Expression Signatures in Peripheral Blood Mononuclear Cells That Correlate Essential Cardiac Function and Aid in Classifying Coronary Artery Disease through a Logistic Regression Model. | Biomedicines | 2023 | 38001953 | PubTator, text mining | PubMed |
| Balancing the interplay of histone deacetylases and non-coding genomes: a step closer to understand the landscape of cancer treatment. | BMC Med Genomics | 2023 | 37978516 | PubTator, text mining | PubMed |
| Utilization of AlphaFold models for drug discovery: Feasibility and challenges. Histone deacetylase 11 as a case study. | Comput Biol Med | 2023 | 37972533 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79885/papers?page=6